ARCHIVES

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

This article is from The Cancer Letter archive.

Vol. 34 No. 07 | February 22, 2008

Download PDF Visit The Full Archive

Related Articles

Cyramza Combination Approved In Advanced Gastric Cancer

November 28, 2014

DeVita Suggest “Overlay Consortium” as Outreach Mechanism for Southern California, Other Areas

September 28, 1984

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

June 29, 2001

Ohio Legislature Gives $1 Million To Cancer Control

August 19, 1983

In Brief: Peter Fischinger Names NCI Deputy Director; ACR Moves Headquarters To Washington Area

November 8, 1985

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007